Stayble Therapeutics AB
559024-8372ActiveDeveloping an injection treatment for pain caused by disc herniation.
Overview
- 5–9
- Employees
- 300–399K SEK
- Revenue
- 2015
- Founded
Key Decision Makers
Andreas Gerward
CEO
Anders Lehmann
Chief Scientific Officer
Erik Kullgren
Chief Financial Officer
Gunnar Fernström
Board member
+4 more contacts in Funnelfeedr
Description
Stayble Therapeutics is a clinical pharmaceutical company focused on developing innovative treatments for debilitating leg pain caused by Lumbar Disc Herniation (LDH). Their core product candidate, STA363, is a patented, disease-modifying treatment administered via a single injection. This therapy a...
Tags
Keywords
Tech Stack
Company Information
- Industry
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Legal Form
- Aktiebolag
- VAT Number
- SE559024837201
Decision Makers
8 contacts in FunnelfeedrAndreas Gerward
CEO
Anders Lehmann
Chief Scientific Officer
Erik Kullgren
Chief Financial Officer
Gunnar Fernström
Board member
Ulf Björklund
Chairman of the Board
Jane Buus Laursen
Board member
Gudrun Anstrén
Board member
Erik Kinnman
Board member
Similar Companies
20 similar companies in FunnelfeedrSynartro AB
1–4 employeesDeveloping sustained local injection treatments for osteoarthritis pain relief.
Paayia Thaimassage
Professional traditional Thai massage services offered in Örebro.
Pharmnovo Aktiebolag
1–4 employeesDeveloping non-addictive delta opioid receptor agonists for neuropathic pain.
Intercedo AB
0 employeesDeveloping medical products focused on improving quality of life.
PILA PHARMA AB
1–4 employeesClinical stage biotech developing an oral obesity and diabetes treatment.
Browse More
Stayble Therapeutics AB Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo